Adma Biologics (ADMA) Deferred Taxes (2024 - 2025)
Adma Biologics (ADMA) reported Deferred Taxes of -$20.9 million for Q4 2025, down 124.76% on a YoY basis from $84.3 million in Q4 2024, and down 534.48% quarter-over-quarter from $4.8 million in Q3 2025.
Adma Biologics (ADMA) Deferred Taxes (2024 - 2025) Analysis & Trends
Adma Biologics has reported Deferred Taxes for 2 years, with the latest figure at -$20.9 million in Q4 2025.
- For the quarter ending Q4 2025, Deferred Taxes fell 124.76% year-over-year to -$20.9 million; the trailing twelve-month figure through Dec 2025 stood at -$11.0 million (down 113.08% YoY), and the FY2025 full-year result was -$11.0 million, down 113.08% from the prior year.
- Deferred Taxes for Q4 2025 stood at -$20.9 million, down from $4.8 million in the prior quarter.
- The five-year high for Deferred Taxes was $84.3 million in Q4 2024, with the low at -$20.9 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -65.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Adma Biologics | 1.98 Bn | 1.89 Bn | 88.82 Mn | -20.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -20.87 Mn |
| Sep 30, 2025 | 4.80 Mn |
| Jun 30, 2025 | 1.62 Mn |
| Mar 31, 2025 | 3.43 Mn |
| Dec 31, 2024 | 84.28 Mn |